Lifecycle Assessment by Benchmark Shows TMC’s NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed 21-03-2023, 19:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users 20-09-2024, 13:44